# Deciphering Mechanisms Underlying Cancer Immunogenicity

> **NCT03958240** · NA · RECRUITING · sponsor: **Institut Claudius Regaud** · enrollment: 1100 (estimated)

## Conditions studied

- Head and Neck Cancer
- Ovarian Cancer
- Cervical Cancer
- Cervical Intraepithelial Neoplasia 3
- Glioblastoma Multiforme of Brain Stem
- Non Small Cell Lung Cancer
- Anal Cancer

## Interventions

- **OTHER:** Blood samples, tumor biopsy specimens and ascites samples will be collected.

## Key facts

- **NCT ID:** NCT03958240
- **Lead sponsor:** Institut Claudius Regaud
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2020-01-17
- **Primary completion:** 2033-01
- **Final completion:** 2033-01
- **Target enrollment:** 1100 (ESTIMATED)
- **Last updated:** 2025-09-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03958240

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03958240, "Deciphering Mechanisms Underlying Cancer Immunogenicity". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03958240. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*